211
Views
7
CrossRef citations to date
0
Altmetric
Original

Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate

&
Pages 444-455 | Received 29 Jul 2008, Accepted 05 Sep 2008, Published online: 17 Jul 2009

References

  • Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. Theophylline particle design using chitosan by the spray drying. Int J Pharm 2004; 270: 167–174
  • Buckton G, Chidavaenzi OC, Koosha F. The effect of spray-drying feed temperature and subsequent crystallization conditions on the physical form of lactose. AAPS PharmSciTech 2002; 3: E37
  • Burjak M, Bogataj M, Velnar M, Grabnar I, Mrhar A. The study of drug release from microspheres adhered on pig vesical mucosa. Int J Pharm 2001; 224: 123–130
  • Chougule MB, Padhi BK, Jinturkar KA, Misra A. Development of dry powder inhalers. Recent Patents Drug Del Formulat 2007; 1: 11–21
  • Corrigan DO, Healy AM, Corrigan OI. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. Eur J Pharm Biopharm 2006; 62: 295–305
  • Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, et al. Large porous particles for pulmonary drug delivery. Science 1997; 276: 1868–1871
  • Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Mirzadeh H, Fakhari A, Nokhodchi A. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. 10., J Microencapsulation. DOI 2008, 1080/02652040802083900
  • Fajac I, Allo JC, Souil E, Merten M, Pichon C, Figarella C, et al. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells. J Gene Med 2000; 2: 368–378
  • Fu J, Fiegel J, Krauland E, Hanes J. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 2002; 23: 4425–4433
  • Harikarnpakdee S, Lipipun V, Sutanthavibul N, Ritthidej GC. Spray-dried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer. AAPS PharmSciTech 2006; 7: E12
  • Koleng JJ, McGinity JW, Carbomer. Handbook of pharmaceutical excipients, 3rd ed, AH Kibbe. Pharmaceutical Press, London 2000; 79–82
  • Kulvanich P, Leesawat P, Patomchaiviwat V. Release characteristics of the matrices prepared from co-spray-dried powders of theophylline and ethylcellulose. Drug Dev Ind Pharm 2002; 28: 727–739
  • Larhrib H, Martin GP, Marriott C, Prime D. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm 2003; 257: 283–296
  • Learoyd TP. Controlled release in inhalation. PhD Thesis. Aston University, BirminghamUK 2007
  • Learoyd TP, Burrows JL, French E, Seville PC. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm 2008a; 68: 224–234
  • Learoyd TP, Burrows JL, French E, Seville PC. Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. 10., Powder Technol. DOI 2008b, 1016/j.powtec.2008.02.015
  • Neau SH, Chow MY, Hileman GA, Durrani MJ, Gheyas F, Evans BA. Formulation and process considerations for beads containing Carbopol 974P, NF resin made by extrusion-spheronization. Int J Pharm 2000; 199: 129–140
  • Noveon. 2002. Controlled release tablets and capsules, Bulletin no. 17. Available online at: http://www.pharma.lubrizol.com/Bulletins/epb17.pdf. Accessed 29/07/08
  • Pringels E, Ameye D, Vervaet C, Foreman P, Remon JP. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery. J Contr Rel 2005; 103: 635–641
  • Rabbani NR, Seville PC. The influence of formulation components on the aerosolisation properties of spray-dried powders. J Contr Rel 2005; 110: 130–140
  • Rao KR, Senapati P, Das MK. Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine. J Microencapsulation 2005; 22: 863–876
  • Sakagami M, Kinoshita W, Sakon K, Sato J, Makino Y. Mucoadhesive beclomethasone microspheres for powder inhalation: Their pharmacokinetics and pharmacodynamics evaluation. J Contr Rel 2002; 80: 207–218
  • Sakagami M, Sakon K, Kinoshita W, Makino Y. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J Contr Rel 2001; 77: 117–129
  • Salama RO, Traini D, Chan HK, Young PM. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. 10., Eur J Pharm Biopharm. DOI 2008, 1016/j.ejpb.2008.04.009
  • Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2004; 57: 235–243
  • Senel S, Capan Y, Hncal AA. Factors affecting the formulation of sustained release potassium chloride tablets. Pharmaceutical technology—controlled drug release, MH Rubenstein, JI Wells. Ellis Horwood, Chichester 1991; 2: 33–42
  • Seville PC, Learoyd TP, Li H-Y, Williamson IJ, Birchall JC. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol 2007a; 178: 40–50
  • Seville PC, Li HY, Learoyd TP. Spray-dried powders for pulmonary drug delivery. Crit Rev Ther Drug Carrier Syst 2007b; 24: 307–360
  • Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The development of a modified dissolution method suitable for investigating powder mixtures. Drug Dev Ind Pharm 2002; 28: 1147–1153
  • Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139–157
  • Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm 2000; 26: 913–924
  • Sivadas N, O’Rourke D, Tobin A, Buckley V, Ramtoola Z, Kelly JG, et al. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm 2008; 358: 159–167
  • Surendrakumar K, Martyn GP, Hodgers EC, Jansen M, Blair JA. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Contr Rel 2003; 91: 385–394
  • Taylor MK, Hickey AJ, VanOort M. Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles. Pharm Dev Technol 2006; 1: 321–336
  • Telko MJ, Hickey AJ. Dry powder inhaler formulation. Respir Care 2005; 50: 1209–1227
  • Ungaro F, De Rosa G, Miro A, Quaglia F, La Rotonda MI. Cyclodextrins in the production of large porous particles: Development of dry powders for the sustained release of insulin to the lungs. Eur J Pharm Sci 2006; 28: 423–432
  • Woolfson AD, McCafferty DF, McCarron PA, Price JH. Bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue. J Contr Rel 1995; 35: 49–58

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.